Kimball Electronics (KE) 2026 KeyBanc Capital Markets Healthcare Forum summary

Company overview and strategic focus

• Operates in automotive, industrial (green and clean), and medical verticals, with a global footprint in North America, Asia, and Europe.

• Recent strategic shift toward healthcare and medical end markets, leveraging electronics and plastics molding capabilities.

• Opened a state-of-the-art CMO facility in Indianapolis, focusing on full medical device assembly and drug delivery systems.

• Facilities support full and final assembly, including cold chain and Class 7/8 cleanroom capabilities.

• Vertical integration enables handling of complex products like auto-injectors, combining electronics and plastics.

Competitive differentiation and growth drivers

• Differentiated by full product assembly, design for manufacturing, and ability to scale production for customers.

• Strong R&D partnerships, helping customers transition solutions to scalable products.

• Growth in medical driven by broad customer base and multiple programs across geographies.

• Auto-injector and drug delivery device expertise positions company for expanding opportunities in the sector.

• Focus on microfluidics, cardio, and surgical instruments as emerging growth areas.

Financial performance and outlook

• Medical segment saw 15% growth in Q2, offsetting declines in automotive and industrial segments.

• Raised full-year revenue guidance to $1.4 billion and improved adjusted income margin to 4.2%-4.5%.

• Gross margin improvement attributed to cost discipline, facility consolidation, and divestiture of non-core assets.

• Long-term margin goal is 6%-7% adjusted operating income, up from current 4%-4.5%.

• Margin expansion expected to be gradual as the medical strategy matures.